DermTech Inc (DMTK)
0.1128
-0.03
(-22.47%)
USD |
NASDAQ |
Jun 20, 11:09
DermTech Cash from Investing (Quarterly): 7.834M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 7.834M |
December 31, 2023 | 12.24M |
September 30, 2023 | 12.76M |
June 30, 2023 | 13.06M |
March 31, 2023 | -8.194M |
December 31, 2022 | 3.539M |
September 30, 2022 | -0.466M |
June 30, 2022 | 0.141M |
March 31, 2022 | -7.533M |
December 31, 2021 | -4.523M |
September 30, 2021 | -7.596M |
June 30, 2021 | -0.178M |
March 31, 2021 | -0.215M |
December 31, 2020 | -2.857M |
September 30, 2020 | -37.28M |
Date | Value |
---|---|
June 30, 2020 | -1.026M |
March 31, 2020 | -0.175M |
June 30, 2019 | |
March 31, 2019 | 136.91M |
December 31, 2018 | 0.00 |
September 30, 2018 | 0.00 |
June 30, 2018 | |
March 31, 2018 | 0.00 |
December 31, 2017 | 0.00 |
September 30, 2017 | 0.00 |
June 30, 2017 | -145.19M |
March 31, 2017 | 0.00 |
December 31, 2016 | 0.00 |
September 30, 2016 | 0.00 |
June 30, 2016 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-37.28M
Minimum
Sep 2020
13.06M
Maximum
Jun 2023
-1.204M
Average
-0.215M
Median
Mar 2021
Cash from Investing (Quarterly) Benchmarks
RadNet Inc | -60.94M |
iSpecimen Inc | 1.937M |
23andMe Holding Co | -2.146M |
Sera Prognostics Inc | -5.689M |
Progyny Inc | 19.34M |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -17.12M |
Cash from Financing (Quarterly) | 0.122M |
Free Cash Flow | -72.07M |
Free Cash Flow Per Share (Quarterly) | -0.4933 |
Free Cash Flow to Equity (Quarterly) | -17.12M |
Free Cash Flow Yield | -1.90K% |